Caris Life Sciences (CAI) Short-term Investments (2024 - 2026)

Caris Life Sciences' Short-term Investments history runs 3 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Short-term Investments changed N/A year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (changed N/A YoY), while the FY2025 annual figure was $2.3 million, up 4.27% from the prior year.
• Short-term Investments for Q1 2026 stood at $2.3 million, up from $2.3 million in the prior quarter.
• The five-year high for Short-term Investments was $2.3 million in Q1 2026, with the low at $1.5 million in Q2 2025.
• The 3-year median for Short-term Investments is $2.3 million (2025), against an average of $2.1 million.
• Peak annual rise in Short-term Investments reached 4.27% in 2025, while the deepest fall reached 4.27% in 2025.
• Caris Life Sciences' Short-term Investments stood at $2.2 million in 2024, then climbed by 4.27% to $2.3 million in 2025, then increased by 0.87% to $2.3 million in 2026.
• Business Quant data shows CAI's Short-term Investments at $2.3 million in Q1 2026, $2.3 million in Q4 2025, and $2.3 million in Q3 2025.